Genomic Testing

Boston, MA – December 2025 – The global Clinical Oncology Next-Generation Sequencing (NGS) market is expanding rapidly as cancer...

TORONTO, Sept. 2, 2025 – Geneseeq Technology Inc. announced that its GeneseeqPrime® NGS Tumor Profiling Assay has received 510(k)...